Valvular surgery is associated with an increased risk of post-operative atrial fibrillation: secondary analysis of the SEARCH-AF CardioLink-1 randomized trial

26 August 2022 (08:00 - 19:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Andrew Ha

University Health Network of Toronto, Toronto (Canada)

6 More presentations in this session

Presentation thumbnail

Early in-hospital discontinuation of aspirin following coronary stent implantation in patients with indication for direct oral anticoagulation

Doctor P. von Stein (Cologne, DE)

Abstract Slides

Presentation thumbnail

Bleeding in patients undergoing percutaneous coronary intervention: factors associated with procedural outcomes and major bleeding complications

Doctor T. Bimal (Port Jefferson, US)

Abstract Slides

Presentation thumbnail

Prevalence and impact of TWILIGHT criteria in all-comer patients undergoing percutaneous coronary intervention

Doctor W. Koh (New York, US)

Abstract Slides

Presentation thumbnail

Determinants of myocardial injury following transcatheter aortic valve implantation: a pre-specified substudy from the POPular TAVI trial

Mr D. van Ginkel (Nieuwegein, NL)

Abstract Slides

Presentation thumbnail

Dual versus single antiplatelet therapy after transcatheter aortic valve replacement: a systematic review and meta-analysis

Doctor R. Eikelboom (Hamilton, CA)

Abstract Slides

Access the full session

Session thumbnail

Pharmacology and bleeding/ischaemica trade-off

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

You may be interested in

Congress Session

Atrial fibrillation (1)

Congress Session

Supraventricular tachycardia (3)

Congress Presentation

Ethanol ablation of left ventricular summit in a patient with repaired congenital heart disease: when the going gets though

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources